Study reveals significantly elevated risk of in-hospital mortality, postoperative infection, and acute kidney injury.
Mean estimated glomerular filtration rate decreases by 0.57 mL/min/1.73 m2 annually with each 1-year increase in age at donation.
Major perioperative complications and death are more likely in patients with chronic kidney disease stages 3-5.
Heavy and binge drinking found to significantly decrease the likelihood of renal dysfunction.
It is associated with better long-term survival and reduced risk of revascularization and myocardial infarction compared with PCI.
Low hemoglobin levels increase the risk of death, sepsis, and cerebrovascular accidents following cardiac surgery.
A history of nephrolithiasis was associated with a nearly 2-fold increased odds of chronic kidney disease in women.
In a study, hypertension, obesity, and higher triglycerides predicted development of chronic kidney disease 30 years later.
Serum bicarbonate could potentially be used to identify patients at elevated risk for chronic kidney disease.
Hepatitis C virus infection increases CKD patients' likelihood of progressing to end-stage renal disease by 32%.
Researchers find no association between sodium excretion and decline in eGFR.
Renal function decline is not accelerated, however.
Korean study also revealed an inverse association between serum homocysteine levels and renal function.
Heart failure, myocardial infarction, or stroke also increase the risk of death prior to ESRD.
If renal replacement therapy planning were started only when patients reached CKD stage 5, many patients would not be adequately prepared, researchers said.
Dr. Moe spoke about the importance of nephrology research and how a prize competition can facilitate the process.
A nearly 5-fold higher risk of Clostridium difficile infection observed in patients with end-stage renal disease requiring dialysis.
Study reveals a more rapid decline in annual eGFR among individuals whose parents had cardiovascular disease.
Many patients still insist that I need to check and manage their cholesterol.
Lower risk of overall mortality, renal replacement therapy seen with more walking.
Cholesterol-lowering therapy is indicated in CKD patients to prevent cardiovascular risk.
Increased maximal carotid artery plaque is associated with a greater likelihood of occlusive coronary disease in patients with and without CKD.
Confirmation of creatinine-based eGFR should be performed in select circumstances using, where appropriate, either measured GFR or cystatin C.
In a 5-year follow-up study, 27 of 28 patients treated with adrenocorticotropic hormone had complete or partial remission.
An eGFR below 45 mL/min/1.73 m2 was associated with a 55% increased risk of death from cancer versus an eGFR of 90 or higher.
In mice with and without CKD, phosphorus levels decreased by an average of 35% by 6 hours after injection with long-acting PTH.
In 3 trials, the annual cost for preventing 1 patient from being transfused varied from $61,188 to $317,988.
Each 0.5 mg/dL increment in phosphorus was associated with a 7% increased risk of anemia.
Ordering process cut the number of epoetin alfa doses by 71% and medication costs by 69%.
In a head-to-head comparison, researchers observed a higher rate of adverse events with iron dextran than iron sucrose or ferric gluconate.